Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Int J Cardiol. 2013 Sep 10;167(6):2588-93. doi: 10.1016/j.ijcard.2012.06.066. Epub 2012 Aug 11.
The arterial switch operation (ASO) is currently the treatment of choice in neonates with transposition of the great arteries (TGA). The outcome in childhood is encouraging but only limited data for long-term outcome into adulthood exist.
We studied 145 adult patients (age>16, median 25 years) with ASO followed at our institution. Three patients died in adulthood (mortality 2.4/1000-patient-years). Most patients were asymptomatic and had normal left ventricular function. Coronary lesions requiring interventions were rare (3 patients) and in most patients related to previous surgery. There were no acute coronary syndromes. Aortic root dilatation was frequent (56% patients) but rarely significant (>45 mm in 3 patients, maximal-diameter 49 mm) and appeared not to be progressive. There were no acute aortic events and no patient required elective aortic root surgery. Progressive neo-aortic-valve dysfunction was not observed in our cohort and only 1 patient required neo-aortic-valve replacement. Many patients (42.1%), however, had significant residual lesions or required reintervention in adulthood. Right ventricular outflow tract lesions or dysfunction of the neo-pulmonary-valve were frequent and 8 patients (6%) required neo-pulmonary-valve replacement. Cardiac interventions during childhood (OR 3.0, 95% CI 1.7-5.4, P<0.0001) were strong predictors of outcome (cardiac intervention/significant residual lesion/death) in adulthood.
Adult patients with previous ASO remain free of acute coronary or aortic complications and have low mortality. However, a large proportion of patients require re-interventions or present with significant right sided lesions. Life-long cardiac follow-up is, therefore, warranted. Periodic noninvasive surveillance for coronary complications appears to be safe in adult ASO patients.
动脉调转术(ASO)目前是大动脉转位(TGA)新生儿的首选治疗方法。儿童时期的结果令人鼓舞,但仅有有限的数据可用于成年后的长期结果。
我们研究了在我们机构接受随访的 145 例成年 ASO 患者(年龄>16 岁,中位数 25 岁)。3 例成年后死亡(死亡率 2.4/1000 患者-年)。大多数患者无症状,左心室功能正常。需要介入治疗的冠状动脉病变很少见(3 例),且大多数与先前的手术有关。没有急性冠状动脉综合征。主动脉根部扩张很常见(56%的患者),但很少有严重的(3 例患者>45mm,最大直径 49mm),且似乎没有进展。没有急性主动脉事件,也没有患者需要择期主动脉根部手术。我们的队列中没有观察到新主动脉瓣功能障碍进行性加重,只有 1 例患者需要新主动脉瓣置换。然而,许多患者(42.1%)在成年后仍有明显的残余病变或需要再次介入治疗。右心室流出道病变或新肺动脉瓣功能障碍很常见,8 例(6%)患者需要新肺动脉瓣置换。儿童时期的心脏介入(OR 3.0,95%CI 1.7-5.4,P<0.0001)是成年后结局(心脏介入/明显残余病变/死亡)的强烈预测因素。
以前接受过 ASO 的成年患者没有急性冠状动脉或主动脉并发症,死亡率低。然而,很大一部分患者需要再次介入治疗或存在明显的右侧病变。因此,需要终身进行心脏随访。定期进行无创冠状动脉并发症监测似乎对成年 ASO 患者是安全的。